Massimo Francalancia

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (4)

Elisabetta Abruzzese

UNIVERSITY TOR VERGATA

ITALY

View details

Sara Leone

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

ITALY

View details

Saeid Najafi-Fard

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

ITALY

View details

Alessandro Sette

Professor and Member

La Jolla Institute for Immunology

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Massimo Francalancia

Research Interests

Explore related searches

Contact this professor

Articles (11)

Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study

Detection of Anti-Rift Valley Fever Virus Antibodies in Serum Samples of Patients with Suspected Arbovirus Infection

Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox Vaccination

Torquetenovirus Loads in Peripheral Blood Predict Both the Humoral and Cell-Mediated Responses to SARS-CoV-2 Elicited by the mRNA Vaccine in Liver Transplant Recipients

Cysteamine exerts in vitro antiviral activity against the SARS-CoV-2 Delta and Omicron variants

Retention of Neutralizing Response against SARS-CoV-2 Omicron Variant in Sputnik V-Vaccinated Individuals

Differential Dynamics of SARS-CoV-2 Binding and Functional Antibodies upon BNT162b2 Vaccine: A 6-Month Follow-Up

Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022

Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies

Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine

Sars-cov-2 serum neutralization assay: A traditional tool for a brand-new virus

Collaborators (4)

Elisabetta Abruzzese

Sara Leone

Saeid Najafi-Fard

Alessandro Sette

Make your next move.